Stock CELU CELULARITY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Celularity Inc.

Equities

CELU

US1511902041

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
3 USD -1.64% Intraday chart for Celularity Inc. -1.64% +21.26%
03-26 Celularity Receives Healthcare Common Procedure Coding System Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance 3L CI
03-20 Celularity Seeks FDA Orphan Drug Status for PDA-002 in Facioscapulohumeral Muscular Dystrophy MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CELULARITY INC. Stock Celularity Inc.
 66.44M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 104B
BIONTECH SE Stock BioNTech SE
 22.41B -
ARGENX SE Stock argenx SE
 22.28B -
GENMAB A/S Stock Genmab A/S
 19.07B
  1. Stock Market
  2. Equities
  3. CELU Stock
  4. Charts Celularity Inc.
  5. Sector Chart